GC tissues; adjacent normal tissues; implanted tumor tissues; lung tissues
HGC27; BGC823; MKN45; SGC7901; MGC803; GES-1
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits); EMT (promotes); autophagy (promotes); ceRNA regulation (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; circRNA-seq; Actinomycin D / DRB Stability Assay; RT-qPCR; FISH / smFISH; Clinical Sample Validation; RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; IHC (Immunohistochemistry); Western Blot; In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis
High circTMEM87A expression is correlated with poor prognosis, worse 3-year OS, tumor size and lymph node metastasis in GC patients; circTMEM87A might be a prognostic biomarker and therapeutic target for GC.
circTMEM87A is up-regulated in gastric cancer tissues and cell lines, and high expression predicts poorer 3-year overall survival. Functionally, circTMEM87A promotes GC cell proliferation, migration, invasion, EMT, autophagy, xenograft tumor growth and metastasis while inhibiting apoptosis. Mechanistically, circTMEM87A acts as a miR-142-5p sponge to elevate ULK1 expression, and its formation is at least partly promoted by QKI.
0.8778
Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p.
combined biological and clinical study